Category

Healthcare

Hims & Hers Dives on FDA Crackdown, Sending Shockwaves Through Weight-Loss Drug Trade cover
CompanyDeep DiveFeb 9, 2026

Hims & Hers Dives on FDA Crackdown, Sending Shockwaves Through Weight-Loss Drug Trade

Hims & Hers (HIMS) took a steep dive after U.S. regulators signaled an aggressive move against compounded versions of blockbuster weight-loss medicines, shaking investor confidence in one of the fastest-growing corners of digital health.

HIMSGLPIP
UnitedHealth Stock Falls as Medicare Surprise Sparks Broad Insurer Selloff cover
CompanyDeep DiveJan 27, 2026

UnitedHealth Stock Falls as Medicare Surprise Sparks Broad Insurer Selloff

Shares of UnitedHealth Group (UNH) took a dive on Tuesday, leading a broad selloff across the health insurance sector after the Trump administration announced a surprise proposal that limits future Medicare Advantage payment growth.

UNHCMS
Nanox’s Bold $800K Bet: Can VasoHealthcare IT Jumpstart U.S. AI Imaging? cover
CompanyDeep DiveNov 28, 2025

Nanox’s Bold $800K Bet: Can VasoHealthcare IT Jumpstart U.S. AI Imaging?

Nanox’s planned acquisition of VasoHealthcare IT signals a strategic push to speed U.S. adoption of its AI imaging tech by adding nationwide integration, data migration, and deployment expertise.

NNOX
Community Health Systems In Play: Why Tenor Health Foundation Could Be Circling This Small-Cap Hospital Operator! cover
CompanyDeep DiveNov 5, 2025

Community Health Systems In Play: Why Tenor Health Foundation Could Be Circling This Small-Cap Hospital Operator!

CYH advances divestiture strategy, selling 3 PA hospitals to Tenor Health Foundation. Deal aligns with leverage reduction and turnaround plan, spotlighting CYH’s value in underserved markets.

CYH
Avanos Medical Could Be WRS Group’s Next Big Buy: Is A Small-Cap Orthopedic Play On The Move? cover
CompanyDeep DiveOct 29, 2025

Avanos Medical Could Be WRS Group’s Next Big Buy: Is A Small-Cap Orthopedic Play On The Move?

Avanos Medical’s sale of its Game Ready unit to WRS Group sharpens focus on core pain and nutrition lines, streamlining operations and sparking fresh acquisition interest.

AVNS
DocGo’s Bold SteadyMD Acquisition Sends Shares Flying—What’s Next? cover
CompanyDeep DiveOct 24, 2025

DocGo’s Bold SteadyMD Acquisition Sends Shares Flying—What’s Next?

DocGo buys virtual care platform SteadyMD in an all-cash deal, boosting its digital health reach. The move excites investors as DocGo gains growth, profit potential, and key new leadership.

DCGO
Talkspace Just Acquired Wisdo—Here’s What It Means For Mental Health AI! cover
CompanyDeep DiveOct 23, 2025

Talkspace Just Acquired Wisdo—Here’s What It Means For Mental Health AI!

ChatGPT said: Talkspace acquires Wisdo Health to strengthen its AI-driven behavioral health platform, adding peer-based support and expanding reach across major healthcare markets.

TALK
HealthStream’s Virsys12 Buy Signals A Strategic Shift Toward The Payer Market! cover
CompanyDeep DiveOct 21, 2025

HealthStream’s Virsys12 Buy Signals A Strategic Shift Toward The Payer Market!

HealthStream acquires Virsys12 for $17M, expanding into the payer market with V12 Enterprise® and strengthening its credentialing suite as it shifts toward a broader healthcare platform strategy.

HSTM
Zepp Health's Bet On Women’s Health With The Wild.AI Buyout: Strategic Leap Or Risky Play? cover
CompanyDeep DiveSep 12, 2025

Zepp Health's Bet On Women’s Health With The Wild.AI Buyout: Strategic Leap Or Risky Play?

Zepp Health, best known for its Amazfit smartwatches, has taken a bold step in health-tech with its acquisition of Wild.AI’s core assets and IP—a leading platform in women’s wellness.

ZEPP
Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments? cover
CompanyDeep DiveSep 9, 2025

Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?

Phreesia is charting new territory with its recently announced $160 million all-cash acquisition of AccessOne Parent Holdings, a healthcare financing firm with a receivables portfolio of $450 million.

PHR
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape cover
CompanyDeep DiveAug 13, 2025

Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape

Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share, valuing the deal at approximately $412 million.

YMAB
Waystar’s $1.25 Billion AI Bet: Can The Iodine Deal Supercharge Its Growth Engine? cover
CompanyDeep DiveJul 31, 2025

Waystar’s $1.25 Billion AI Bet: Can The Iodine Deal Supercharge Its Growth Engine?

Waystar, a leading healthcare payments platform, has announced its plan to acquire health AI company Iodine Software for $1.25 billion in a mix of cash and stock.

WAY
DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors! cover
CompanyDeep DiveJul 15, 2025

DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors!

DexCom has undergone a major strategic reset after a turbulent 2024, and all eyes are now on its bold shift toward the vastly underpenetrated Type 2 diabetes market.

DXCM
Hims & Hers Stock Plunges After Novo Nordisk Breakup: What Really Happened? cover
CompanyDeep DiveJul 3, 2025

Hims & Hers Stock Plunges After Novo Nordisk Breakup: What Really Happened?

Hims & Hers Health saw its stock crash by over 35% in a matter of days after Novo Nordisk announced the termination of its short-lived partnership over the weight loss drug Wegovy.

HIMSNVO
Healthcare Stocks: Once a Safe Bet, Healthcare Now Faces New Market Headwinds cover
HealthcareNewsApr 28, 2025

Healthcare Stocks: Once a Safe Bet, Healthcare Now Faces New Market Headwinds

Healthcare stocks have long been considered a safe and reliable bet for investors seeking stability during turbulent times.

HHS
Healthcare Stocks: Thriving Amidst Economic Uncertainty cover
BreakingHealthcareOct 27, 2023

Healthcare Stocks: Thriving Amidst Economic Uncertainty

Despite economic concerns, the sell-off in big tech, rising interest rates and a looming recession, healthcare stocks are still going strong.

ALECFTDVCYTFNA
Skylight Health Executes Definitive Agreement to Acquire NeighborMD to Expand in Florida and Enters Medicare Advantage Global Risk
HealthcareNewsMay 3, 2022

Skylight Health Executes Definitive Agreement to Acquire NeighborMD to Expand in Florida and Enters Medicare Advantage Global Risk

Skylight executes a definitive agreement for the largest acquisition to date and secured a US $20 million credit line facility to fund the acquisition and future deals NeighborMD (“NMD”) adds 9 practices across Central and Southern Florida with over 2,400 owned and affiliated global capitated risk lives. Trailing 12 months (TTM) primary care revenue of ...

SLHG
Healthcare Triangle Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
HealthcareNewsApr 20, 2022

Healthcare Triangle Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

HITRUST Risk-based, 2-year Certification validates Healthcare Triangle is committed to meeting key regulations and protecting sensitive information PLEASANTON, Calif., April 20, 2022 – Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the "Company"), a leading provider of cloud and data transformation solutions for healthcare and life sciences, today annou

HCTI
Watch the Eyes.
HealthcareApr 7, 2020

These Eye Problems Could Be Symptoms Of COVID-19 Coronavirus

Looks like the eyes may have it. You know those round things that sit below your forehead and you use to “wink and gun” at people? Well, add them to the growing list of body parts that may be affected by the COVID-19 coronavirus. A study recently published in JAMA Ophthalmology found that 31.6% of 38 consecutive patients with COVID-19 ...

COVIDJAMASARS
NanoKnife FDA Approval Is The Highlight Of An Otherwise Tepid AngioDynamics Quarter
BiotechHealthcareApr 3, 2019

NanoKnife FDA Approval Is The Highlight Of An Otherwise Tepid AngioDynamics Quarter

Latham, New York: AngioDynamics, Inc. (NASDAQ:ANGO) is a number one supplier of modern, minimally invasive medical units utilized by skilled healthcare suppliers for vascular entry, peripheral vascular illness, and oncology. It just lately reported its monetary outcomes for the third quarter of the fiscal 12 months 2019 ending 28th February 19 whereby the co

ANGO
Lexicon’s Volatility Could Be Your Friend After The Zynquista Rejection
BiotechHealthcareApr 2, 2019

Lexicon’s Volatility Could Be Your Friend After The Zynquista Rejection

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is an organization identified for locating novel drug targets and drug candidates developed from state-of-the-art medicinal chemistry and proprietary gene. The firm lately produced a superb outcome beating Wall Street expectations with the administration anticipating a 20% income development in 2019, pushed by Euro

LXRXSNY
Women’s Health Player, Establishment Labs Witnesses Rising Implant Sales; Delivers Mixed Results
BusinessHealthcareMar 21, 2019

Women’s Health Player, Establishment Labs Witnesses Rising Implant Sales; Delivers Mixed Results

New York, NY: Establishment Labs Holdings Inc. (NASDAQ:ESTA), is a world medical know-how firm centered on ladies’s health, within the breast aesthetics and reconstruction market, by designing, growing, manufacturing and advertising an revolutionary portfolio of silicone gel-filled breast implants. It not too long ago reported monetary outcomes for the fourt

ESTA
Amphastar Had A Good 2018 With Multiple ANDA Approvals
HealthcareNewsMar 18, 2019

Amphastar Had A Good 2018 With Multiple ANDA Approvals

Rancho Cucamonga, CA: Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) is a specialty pharmaceutical firm that focuses totally on creating, manufacturing, advertising, and promoting technically-challenging generic and proprietary injectable, inhalation, intranasal merchandise, and insulin API merchandise. It launched its outcomes for the fourth quarter and full

AMPH
Aerie Pharmaceuticals Delivers Mixed Result; Focus On International Expansion
BiotechHealthcareFeb 27, 2019

Aerie Pharmaceuticals Delivers Mixed Result; Focus On International Expansion

Durhan, NC: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a scientific stage pharmaceutical firm targeted on offering therapies for the therapy of eye-related illnesses, launched its quarterly outcomes for the interval ended December 31,2018. The firm delivered its third consecutive blended outcome with a income beat however with an earnings miss. The administr

AERI
The Cancer Research Collaboration Partners with Diabetes Prevention Program Provider Blue Mesa Health with California Residents in Mind Nasdaq:RDNT
BiotechHealthcareDec 17, 2018

The Cancer Research Collaboration Partners with Diabetes Prevention Program Provider Blue Mesa Health with California Residents in Mind Nasdaq:RDNT

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) — The Cancer Research Collaboration (CRC), a non-profit group devoted to increasing the supply of cutting-edge most cancers analysis, in partnership with RadNet, Inc. (Nasdaq:RDNT), a nationwide market chief offering high-quality, cost-effective diagnostic imaging providers by a community of fully-owned and oper

RDNT
SCD
HealthcareNewsDec 14, 2018

Sienna Announces December Dividend Toronto Stock Exchange:SIA.TO

[ad_1] MARKHAM, Ontario, Dec. 14, 2018 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) at the moment introduced a dividend of $0.0765 per frequent share of the Company (every, a “Common Share”) for the month of December 2018, representing $0.918 per Common Share on an annualized foundation. The dividend can ...

SIATOGLOBETSX
Evitrade Health Systems (EVA-CNX) Setting Up to be the Breakout Stock of 2018
HealthcareNewsNov 21, 2018

Evitrade Health Systems (EVA-CNX) Setting Up to be the Breakout Stock of 2018

Disclaimer :This is a paid advertisement and all individuals should verify all claims and perform their own due diligence on ​​EVA (and / or any other mentioned companies and / or securities), and read this disclaimer in its entirety.Small Cap Exclusive profiles are not a solicitation or recommendation to buy, sell or hold securities. Small...

AXHLF